SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Silo Pharma, Inc. (SILO) News

Follow Silo Pharma, Inc. (SILO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SILO Asset equity Sector Markets 90 days 4 Last 1.73 Updated Oct 14, 2026, 08:33 PM UTC Open live news feed Open SILO chart & news
M Silo Pharma Acquires Software and IP Assets for 150,000 Shares Silo Pharma entered an asset purchase agreement to acquire software and related intellectual property from Larry King, issuing 150,000 common shares as consideration. The shares are subject to a lock-up of up to 12 month EQUITY | Oct 14, 2026, 08:33 PM UTC M Silo Pharma Acquires Software and IP From Norsight; Issues Warrant Silo Pharma entered into an asset purchase agreement to acquire software, technology, and related intellectual property from Norsight. As consideration, the company issued a warrant to purchase up to 300,000 shares at $1 EQUITY | Oct 02, 2026, 08:43 PM UTC L SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio NEWS | Sep 18, 2026, 12:50 PM UTC L SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum EQUITY | Sep 09, 2026, 01:15 PM UTC L Silo Pharma gets notice of allowance for Canadian PTSD patent application Silo Pharma (SILO) received a notice of allowance for a Canadian patent application covering a novel PTSD treatment, per the TradeXchange Newsdesk alert. REGULATION | Aug 18, 2026, 08:15 PM UTC M Silo Pharma Subsidiary Collaborates with Caylent Silo Pharma subsidiary partners with Caylent EQUITY | Aug 06, 2026, 12:50 PM UTC L SILO Silo Pharma files to sell 1.91M shares of common stock for holders SILO Silo Pharma files to sell 1.91M shares of common stock for holders EQUITY | Jul 24, 2026, 08:07 PM UTC L SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credi SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credits, AI development Tools and technical resources to support next-generation ente EQUITY | Jul 14, 2026, 12:58 PM UTC M SILO: Reports Positive Data Silo Pharma reports positive stability data for SPC-15 PTSD treatment, advancing program toward first-in-human clinical trial EARNINGS | Jun 23, 2026, 12:23 PM UTC